Octagon has released a new process management platform that provides foundation for data, document, and submission management.
OCTAGON RESEARCH SOLUTIONS, INC. LAUNCHES VIEWPOINT® QUANTUM PLATFORMProcess management platform provides foundation for data, document and submission management.
(WAYNE, PA, November 6, 2008) - CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leading provider of breakthrough software and services to the life sciences industry, today announced the release of the ViewPoint®Quantum platform. The platform supports optional business modules and is the foundation for the ViewPoint Quantum environment, which provides management and control of complex processes across the R&D enterprise. ViewPoint Quantum is the industry’s first comprehensive solution to connect content, people, processes and technologies by aligning and automating work efforts for challenging processes such as maintenance and management of standards implementations and content and submission management.
The ViewPoint Quantum platform provides Business Process Management capabilities including workflow, issue management, search, metadata and document storage, as well as integrated connectivity with other content repositories. It also ensures that common functionality will be available across critical business modules including dynamic reporting capabilities, issue management capabilities and powerful workflows that are the basis for cross-functional efficiency.
The launch of the platform will be followed by subsequent releases of business modules that provide functionality to support submission standards such as eCTD (electronic Common Technical Document) and CDISC (Clinical Data Interchange Standards Consortium) and complex activities relating to these standards such as global submission publishing, compilation and lifecycle management. Monique Garrett, vice president, Marketing, Octagon Research Solutions, Inc., noted, “The ViewPoint Quantum platform represents the first milestone in our rolling launch strategy. ViewPoint Quantum combines the ease and usability of desktop tools with the power of a platform approach. We believe that the market has outgrown disaggregated and disposable desktop tools and is looking for a long-term, approach to managing complex processes.”
Kirk Gallion, president, Octagon Research Solutions, Inc., added, “This is an educated marketplace and one that is seeking real-time solutions from a technology and a resourcing perspective. The ViewPoint Quantum platform enables us to deliver our expert services through our Integrated Sourcing model, which provides the technology and resources that clients need to complete their submission capabilities. The power of utilizing one environment to manage resources, emerging content (data and documents), final submission deliverables and any issues associated with the process is compelling and seems to be resonating throughout industry.”
Octagon will be demonstrating ViewPoint Quantum at their exhibit booth (#5) at the DIA 7th Annual Electronic Submissions Conference: “eCTD, The Adventure Continues”, in San Diego, CA on November 6-7, 2008.
For more information about ViewPoint Quantum or to learn more about Octagon’s people, process and technology, please visit www.viewpointquantum.com. To schedule a demonstration, please contact Octagon Research Solutions, Inc. at 610.535.6500.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. Octagon’s EDC Operations are located in Mountain View, CA. For more information please visit www.octagonresearch.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.